Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/33206
Title: Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: the 2010 GLADAOF Lecture
Authors: Fernando Arevalo, J.
Sanchez, Juan G.
Lasave, Andres F.
Wu, Lihteh
Maia, Mauricio [UNIFESP]
Bonafonte, Sergio
Brito, Miguel
Alezzandrini, Arturo A.
Restrepo, Natalia
Berrocal, Maria H.
Saravia, Mario
Farah, Michel Eid [UNIFESP]
Fromow-Guerra, Jans
Morales-Canton, Virgilio
Caracas Clin Opthalmol Ctr
INIO
Inst Cirugia Ocular
Universidade Federal de São Paulo (UNIFESP)
Ctr Oftalmol Bonafonte
IDEO
Univ Buenos Aires
Univ Puerto Rico
Hosp Univ Austral
Asociac Evitar Ceguera Mexico 04030
Issue Date: 1-Jan-2011
Publisher: Hindawi Publishing Corporation
Citation: Journal of Ophthalmology. New York: Hindawi Publishing Corporation, 13 p., 2011.
Abstract: This paper demonstrates multiple benefits of intravitreal bevacizumab (IVB) on diabetic retinopathy (DR) including diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) at 24 months of followup. This is a retrospective multicenter interventional comparative case series of intravitreal injections of 1.25 or 2.5 mg of bevacizumab for DME, PDR without tractional retinal detachment (TRD), and patients who experienced the development or progression of TRD after an intravitreal injection of 1.25 or 2.5 mg of bevacizumab before vitrectomy for the management of PDR. the results indicate that IVB injections may have a beneficial effect on macular thickness and visual acuity (VA) in diffuse DME. Therefore, in the future this new therapy could complement focal/grid laser photocoagulation in DME. in PDR, this new option could be an adjuvant agent to panretina photocoagulation so that more selective therapy may be applied. Finally, TRD in PDR may occur or progress after IVB used as an adjuvant to vitrectomy. Surgery should be performed 4 days after IVB. Most patients had poorly controlled diabetes mellitus associated with elevated HbA1c, insulin administration, PDR refractory to panretinal photocoagulation, and longer time between IVB and vitrectomy.
URI: http://repositorio.unifesp.br/handle/11600/33206
ISSN: 2090-004X
Other Identifiers: http://dx.doi.org/10.1155/2011/584238
Appears in Collections:Em verificação - Geral

Files in This Item:
File Description SizeFormat 
WOS000306790100022.pdf4.72 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.